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Introduction
Upon catalyzing the cleavage of RNA, RNases operate
at the crossroads of transcription and translation.
Bovine pancreatic RNase A (EC 3.1.27.5) is the best
characterized RNase. A notoriously stable enzyme,
RNase A retains its catalytic activity at temperatures
near 100  C or in otherwise denaturing conditions
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Molecular probes are useful for both studying and controlling the functions
of enzymes and other proteins. The most useful probes have high afﬁnity
for their target, along with small size and resistance to degradation. Here,
we report on new surrogates for nucleic acids that fulﬁll these criteria.
Isosteres in which phosphoryl [R–O–P(O2
))–O–R¢] groups are replaced
with N-acylsulfonamidyl [R–C(O)–N
)–S(O2)–R¢] or sulfonimidyl [R–S(O2)–
N
)–S(O2)–R¢] groups increase the number of nonbridging oxygens from
two (phosphoryl) to three (N-acylsulfonamidyl) or four (sulfonimidyl). Six
such isosteres were found to be more potent inhibitors of catalysis by
bovine pancreatic RNase A than are parent compounds containing phos-
phoryl groups. The atomic structures of two RNase AÆN-acylsulfonamide
complexes were determined at high resolution by X-ray crystallography.
The N-acylsulfonamidyl groups were observed to form more hydrogen
bonds with active site residues than did the phosphoryl groups in analo-
gous complexes. These data encourage the further development and use of
N-acylsulfonamides and sulfonimides as antagonists of nucleic acid-binding
proteins.
Database
Structural data for the two RNase A complexes are available in the Protein Data Bank under
accession numbers 2xog and 2xoi
Abbreviations
PDB, Protein Data Bank; UpA, uridylyl(3¢ﬁ5¢)adenosine.
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In humans, angiogenin (RNase 5) is an inducer of
neovascularization, and plays an important role in
tumor growth [5]. Eosinophil-derived neurotoxin
(RNase 2) and eosinophil cationic protein (RNase 3)
have antibacterial and antiviral activities. An amphib-
ian homolog, onconase, has antitumor activity with
clinical utility [6]. Even secretory RNases from the ze-
braﬁsh share the RNase A scaffold [7]. Small-molecule
inhibitors of these RNases could be used to investigate
their broad biological functions.
The afﬁnity of RNase A for RNA derives largely
from hydrogen bonds [8], especially with the active
site residues [9] and nucleobase [10]. The most potent
small-molecule inhibitors of RNase A closely resemble
RNA [11–17], and likewise form numerous hydrogen
bonds with the enzyme. Pyrophosphoryl groups have
four nonbridging oxygens, providing more oppor-
tunity for the formation of hydrogen bonds than
is possible with a phosphoryl group. Accordingly,
5¢-diphosphoadenosine 3¢-phosphate and 5¢-diphospho-
adenosine 2¢-phosphate exhibit strong afﬁnity for
RNase A [18], owing to extensive hydrogen-bonding
interactions [19]. Pyrophosphoryl groups, however,
have ﬁve rather than three backbone atoms. We
reasoned that isosteres with additional nonbridging
oxygen atoms but only three backbone atoms could
be advantageous.
Much recent work has employed sulfur as the foun-
dation for nucleoside linkers with multiple nonbridging
oxygens. For example, achiral linkages have been
made with a sulfone [R–S(O2)–R¢] [20], sulfonate ester
[R–S(O2)–O–R¢] [21,22], sulfonamide [R–S(O2)–NH–
R¢] [23], sulfamate [R–O–S(O2)–NH–R¢] [24], sulfamide
[R–NH–S(O2)–NH–R¢] [25,26], and N-acylsulfamate
[R–O–S(O2)–NH–C(O)–R¢] [27]. Of these functional
groups, only the N-acylsulfamyl group has more non-
bridging oxygens than does a phosphoryl group, but
its length – four backbone atoms – compromises its
utility as a surrogate.
We were intrigued by sulfonamides because of the
relatively high anionicity of their nonbridging oxygens.
Sulfonamide-linked nucleosides were employed ﬁrst in
antisense technology, where they were found to be
highly soluble, and resistant to both enzyme-catalyzed
and nonenzymatic hydrolysis [28,29]. Unlike this previ-
ous study, however, we chose to examine sulfonamides
that were modiﬁed on nitrogen to install additional
nonbridging oxygens.
We began our work by assessing the afﬁnity of
RNase A for two nucleic acid mimics that contain
sulfonimide linkers [R–S(O2)–NH–S(O2)–R¢], which
have four nonbridging oxygens. We compared these
mimics to a parent molecule that contains canonical
phosphate linkers. Then, we assessed two mononucleo-
sides and two dinucleosides containing an N-acylsulf-
onamide linker [R–S(O2)–NH–C(O)–R¢], which has
three nonbridging oxygens, in the place of a phos-
phoryl group. Finally, we determined the crystal struc-
tures of two N-acylsulfonamide-linked dinucleosides in
complexes with RNase A. Together, our data lead to
comprehensive conclusions regarding a new class of
surrogates for the phosphoryl group.
Results and Discussion
Sulfonimides as inhibitors of RNase A
We began by determining the ability of three backbone
analogs of RNA to inhibit catalysis by RNase A.
These analogs have a simple polyanionic backbone
with neither a ribose moiety nor a nucleobase (Fig. 1).
In tetraphosphodiester 1, three carbon atoms separate
the phosphoryl groups, mimicking the backbone of
RNA but without the torsional constraint imposed by
a ribose ring. To reveal a contribution from additional
nonbridging oxygen atoms on enzyme inhibition, we
used tetrasulfonimide 2, which has three carbon atoms
between its sulfonimidyl groups, and tetrasulfoni-
mide 3, which has six.
Under no-salt conditions, which encourage Coulom-
bic interactions, we could only set a lower limit of
Ki >1 0m m for tetraphosphodiester 1 (Table 1). Pre-
viously, we reported that RNase A binds to a tetranu-
cleotide containing four phosphoryl groups with
Fig. 1. Chemical structures of RNA, tetraphosphodiester 1, and
tetrasulfonimides 2 and 3.
N-acylsulfonamide-linked dinucleoside inhibitors of RNase A N. Thiyagarajan et al.
542 FEBS Journal 278 (2011) 541–549 ª 2011 The Authors Journal compilation ª 2011 FEBSKd = 0.82 lm under low-salt conditions [30]. Thus, we
conclude that the ribose moiety and nucleobase of a
nucleic acid increase its afﬁnity for RNase A by
>1 0
4-fold.
Then, we found that tetrasulfonimide 2 inhibits
catalysis by RNase A with Ki = 0.11 mm under no-
salt conditions (Table 1). Apparently, the additional
nonbridging oxygens of tetrasulfonimide 2 provide
>1 0
2-fold greater afﬁnity for RNase A. In the pres-
ence of 0.10 m NaCl, the Ki value of tetrasulfonimide 2
increased by 80-fold, indicating that binding had a
Coulombic component [31,32]. This ﬁnding is consis-
tent with RNase A (pI 9.3) [33] being cationic and
each sulfonimidyl group (N–H pKa = )1.7) [34] being
anionic in aqueous solution.
Finally, we found that tetrasulfonimide 3 inhibits
catalysis with Ki = 0.33 ± 0.07 mm under no-salt
conditions (Table 1). The slightly weaker afﬁnity of
tetrasulfonimide 3 than of tetrasulfonimide 2 is consis-
tent with the spacing of their sulfonimidyl groups.
RNase A has four well-deﬁned phosphoryl group-bind-
ing subsites [35,36]. The spacing of the sulfonimidyl
groups in tetrasulfonimide 2 is analogous to that of
the phosphoryl groups in a nucleic acid (Fig. 1), and
these sulfonimidyl groups are poised to occupy the
enzymatic subsites for phosphoryl groups. In compari-
son, the separation between the sulfonimidyl groups
in tetrasulfonimide 3 is too large.
N-Acylsulfonamide-linked dinucleosides
as inhibitors of RNase A
Given the efﬁcacy of the sulfonimidyl group as a phos-
phoryl group surrogate, we sought to determine the
advantage of adding nonbridging oxygens to a nucleic
Table 1. Constants for inhibition of RNase A catalysis by com-
pounds 1–7.
Compound Ki (mM), no salt
a Ki (mM), 0.10 M salt
b
Tetraphosphodiester 1 >1 0 N D
Tetrasulfonimide 2 0.11 ± 0.02 8.3 ± 1.7
Tetrasulfonimide 3 0.33 ± 0.07   10
N-acylsulfonamide 4 ND 5.3 ± 0.5
N-acylsulfonamide 5 ND 4.8 ± 0.3
N-acylsulfonamide 6 ND 0.46 ± 0.03
N-acylsulfonamide 7 ND 0.37 ± 0.01
a Values (±standard error) in 0.05 M Bistris⁄HCl buffer at pH 6.0.
b Values (±standard error) in 0.05 M Mes⁄NaOH buffer at pH 6.0,
containing NaCl (0.10 M).
Fig. 2. Chemical structures of N-acylsulfonamide-linked nucleo-
sides 4–7.
A
B
Fig. 3. Isotherms for the binding of N-acylsulfonamide-linked dinu-
cleosides to RNase A. Data were ﬁtted to Eqn (1). (A) N-acylsulf-
onamide 7, Ki = (3.7 ± 0.1) · 10
)4 M. (B) N-acylsulfonamide 6,
Ki = (4.6 ± 0.3) · 10
)4 M.
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group, which has three nonbridging oxygen atoms and
is anionic (N–H pKa = 4–5) [34]. In compounds 4–7
(Fig. 2; Fig. S1), an N-acylsulfonamidyl group replaces
the phosphoryl group in AMP or uridylyl(3¢ﬁ5¢)
adenosine (UpA). We found that each of these com-
pounds inhibited catalysis by RNase A more than did
tetrasulfonimide 2 or tetrasulfonimide 3, which are not
nucleosides (Fig. 3; Table 1). The two AMP analogs
inhibited RNase A with Ki values of   5m m.I n
contrast, AMP itself has a Ki of 33 mm [37]. The two
UpA analogs inhibited RNase A with Ki values of
  0.4 mm (Table 1). In contrast, thymidylyl(3¢ﬁ5¢)
2¢-deoxyadenosine inhibits RNase A with Ki = 1.2 mm
[9]. We conclude that replacing a single phosphoryl
group with an N-acylsulfonamidyl group confers
an approximately ﬁve-fold increase in afﬁnity for
RNase A.
Of compounds 1–7, RNase A binds most tightly
with N-acylsulfonamides 6 and 7. These inhibitors clo-
sely mimic a natural substrate for RNase A, UpA
[38,39], which is cleaved by the enzyme with a rate
enhancement of nearly a trillion-fold [40]. Accordingly,
we decided to investigate their interactions with
RNase A in detail by using X-ray crystallography.
Three-dimensional structures of RNase AÆN-acyl-
sulfonamide-linked nucleoside complexes
The three-dimensional structures of N-acylsulfona-
mides 6 and 7 in complex with RNase A were deter-
mined by X-ray crystallography (Table 2). The
structures were solved to a resolution of 1.72 A ˚ by
molecular replacement in a centered monoclinic (C2)
space group with two molecules per asymmetric unit.
N-Acylsulfonamides 6 and 7 (Fig. 2) bound at the
active site of RNase A are more fully observed in mol-
ecule A (Fig. 4). In molecule B, only adenine nucleo-
sides are apparent (an observation similar to those
made with RNase A–inhibitor complexes reported
previously by us in this space group). Alternative con-
formations for some parts of N-acylsulfonamide 7,
highlighting the ﬂexibility around the ribose moieties,
are observed and are built into the structure. A similar
alternative conformation was not observed for N-acyl-
sulfonamide 6.
Table 2. X-ray data collection and reﬁnement statistics. Rsymm = Rh Ri |I(h) ) Ii(h)|⁄Rh RiIi(h), where Ii(h) and I(h) are the ith and the mean
measurements of the intensity of reﬂection h, respectively. Rcryst = Rh |Fo ) Fc|⁄RhFo, where Fo and Fc are the observed and calculated
structure factor amplitudes of reﬂection h, respectively. Rfree is equal to Rcryst for a randomly selected 5.0% subset of reﬂections not used
in the reﬁnement.
RNase AÆN-acylsulfonamide 7 RNase AÆN-acylsulfonamide 6
Space group C2 C2
Cell dimensions a = 101.0 A ˚ a = 101.0 A ˚
b = 33.1 A ˚ b = 33.2 A ˚
c = 72.6 A ˚ c = 72.8 A ˚
a = c =9 0   a = c =9 0  
b = 90.4  b = 90.9 
Resolution range (A ˚) 50–1.72 50–1.72
Rsymm (outer shell) 0.060 (0.171) 0.062 (0.192)
I⁄rI (outer shell) 17.5 (6.0) 17.2 (5.7)
Completeness (outer shell) (%) 98.5 (94.5) 98.0 (92.7)
Total no. of reﬂections 174 818 186 775
Unique no. of reﬂections 26 158 26 200
Redundancy (outer shell) 3.0 (2.8) 3.1 (2.9)
Wilson B-factor (A ˚ 2) 17.8 18.1
Rcryst⁄Rfree 0.212⁄0.246 0.214⁄0.244
Average B-factor (A ˚ 2)
Overall 18.1 18.3
Protein (chain A, B) 16.2, 16.5 16.4, 16.3
Ligand 21.8, 56.0 34.2, 43.2
Solvent 26.5 25.6
rmsd
Bond length (A ˚) 0.007 0.007
Bond angle ( ) 1.439 1.113
PDB codes 2xog 2xoi
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mide 7 (2¢-oxy) differ by only one atom. These two
dinucleotide isosteres adopt a similar conformation
upon binding to RNase A, and occupy the same enzy-
mic subsites as do the dinucleotides cytidylyl(3¢ﬁ5¢)
adenosine [Protein Data Bank (PDB) code 1r5c] [41]
and UpA (PDB code 11ba) [42]. The structure of
N-acylsulfonamide 7 was reﬁned with full occupancy,
except for the alternative conformations observed for
the N-acylsulfonamidyl group and the addition of O2¢.
The value of the nucleoside torsion angle v (Table S1)
indicates that the compounds are bound in an anti
conformation, which is the preferred orientation for
bound adenine and pyrimidines [43]. The two ribose
moieties exhibit a high degree of ﬂexibility, as
expected. The backbone torsion angle d for the bound
ribose units is in an unfavorable conformation, repre-
senting neither a bound nor an unbound state,
although the c torsion angle represents the bound state
for ribose units with ±sc.I nN-acylsulfonamide 7, the
c torsion angle for the ribose of adenine exhibits an
unfavorable +ac puckering in one of its alternative
conformations.
The pseudorotation angles for the uridine of N-acyl-
sulfonamide 7 were found in both the C3¢-endo (N)
conformation and the O4¢-endo conformation, whereas
the C3¢-endo conformation was preferred for N-acyl-
sulfonamide 6.C 3¢-endo puckering had been observed
previously for bound uridylyl(2¢ﬁ5¢)adenosine
[42], 2¢-CMP [44], and diadenosine 5¢,5¢¢,5¢¢¢-P¢,P¢¢,P¢¢¢
triphosphate (Ap3A) [17]. Solution NMR studies have
shown that the C3¢-endo puckering is a predominant
state for unbound furanose rings [44,45]. O4¢-endo
puckering is an unusual conformation, and was
observed in the complexes of RNase A with 2¢-ﬂuoro-
2¢-deoxyuridine 3¢-phosphate [11] and Ap3A [17]
(Fig. 5).
Hydrogen bonding in RNase AÆN-acylsulfonamide-
linked nucleoside complexes
The hydrogen-bonding pattern exhibited by the nucle-
obases is conserved in both the 2¢-oxy (7) and
2¢-deoxy (6) N-acylsulfonamides (Table S2). In both
structures, the bound inhibitors span the nucleo-
base-binding subsites. Surprisingly, however, the
N-acylsulfonamidyl groups point away from the active
site (Figs 4 and 5). In N-acylsulfonamide 7,O 2S of the
N-acylsulfonamidyl group forms hydrogen bonds with
active site residues His119 and Asp121 (mediated by a
water molecule). In one of its alternative states, O1S
of the N-acylsulfonamidyl group forms a hydrogen
bond with Lys41. In N-acylsulfonamide 6, where only
a single conformation was observed for the bound
N-acylsulfonamidyl group, O2S forms two hydrogen
bonds with His119 and Asp121 (mediated by a water
A
B
C
D
Fig. 4. (A, B) Schematic and stereo representation of hydrogen
bonds in the RNase A complex with N-acylsulfonamide 7 and
N-acylsulfonamide 6, respectively. N-Acylsulfonamide 7 and N-acyl-
sulfonamide 6, gold; active site residues, pea-green; RNase A, gray.
Hydrogen bonds are represented as dashed lines, and water mole-
cules are in cyan. (C, D) Stereo pictures of 2Fo ) Fc contoured at
1.0r for N-acylsulfonamide 7 and N-acylsulfonamide 6, respectively.
N. Thiyagarajan et al. N-acylsulfonamide-linked dinucleoside inhibitors of RNase A
FEBS Journal 278 (2011) 541–549 ª 2011 The Authors Journal compilation ª 2011 FEBS 545molecule). Thus, replacing a phosphoryl group with
an N-acylsulfonamidyl group leads to new hydrogen-
bonding interactions.
RNase A cleaves UpA and UpG uridylyl(3¢ﬁ5¢)
guanosine (UpG) with similar Km values but signiﬁ-
cantly different kcat values [46]. The similarity in the
Km values is attributable to the uracil moiety binding
in the same fashion [38], which could trigger the initial
binding of both substrates. In UpG, the binding of the
guanine moiety is deterred by exocyclic O6. Close
inspection shows that the relevant subsite of RNase A
has a negative potential and hence cannot accommo-
date an electronegative atom. In contrast, the exocyclic
N6-amino group of adenine forms a hydrogen bond
with the side chain of Asn71, increasing the afﬁnity of
RNase A for UpA. This hydrogen bond is apparent in
the complexes with N-acylsulfonamides 6 and 7
(Table S2; Fig. 4).
In all reported RNase AÆnucleotide complexes, at
least one atom of ribose (either O2¢ or O3¢) appears to
interact intimately with the enzyme. The ribose unit of
uridine in N-acylsulfonamide 7 forms four hydrogen
bonds. O4¢ shares two hydrogen bonds with the
enzyme, and O2¢ forms two additional hydrogen bonds
in each of its conformations. Thus, in either observed
conformation of N-acylsulfonamide 7, there are a total
of four hydrogen bonds formed by the uridine ribose.
Of the two hydrogen bonds exhibited by these two
atoms, one is a direct interaction with the enzyme and
the other is mediated by a water molecule. In the com-
plex with N-acylsulfonamide 6, which lacks an O2¢,
only O4¢ of the uridine ribose forms hydrogen bonds
with the enzyme. O5¢ of the adenosine ribose forms a
hydrogen bond with active site residue His119 in its
alternative form in N-acylsulfonamide 7.
Overall, N-acylsulfonamide 7 and N-acylsulfona-
mide 6 exhibit 12(12) and 8(11) hydrogen bonds with
RNase A (including solvent-mediated interactions in
parentheses), respectively (Table S2). These numbers
are comparable to those in the complexes with uri-
dylyl(2¢ﬁ5¢)adenosine [10(5)] [42], 3¢-CMP [11(2)]
[46], and 2¢-deoxycytidylyl(3¢ﬁ5¢)2¢-deoxyadenosine
[10(5)] [47]. Thus, replacing a phosphoryl group with
an N-acylsulfonamidyl group can recapitulate, or even
enhance, the characteristic structural interactions of a
nucleic acid with a protein.
Conclusions
The functional and structural studies presented herein
demonstrate the attributes of N-acylsulfonamidyl and
sulfonimidyl groups as surrogates for the phosphoryl
groups of nucleic acids. The structural complexes
of two N-acylsulfonamide-linked nucleosides with
RNase A closely mimic the binding by nucleic acids.
The attributes and versatility of N-acylsulfonamidyl
and sulfonimidyl groups are ripe for exploitation in
the creation of nucleic acid surrogates.
Experimental procedures
A ﬂuorogenic RNase substrate, 6-FAM–dArUdAdA–
6-TAMRA (where 6-FAM is a 6-carboxyﬂuorescein group
at the 5¢-end and 6-TAMRA is a 6-carboxytetramethyl-
rhodamine group at the 3¢-end), was from Integrated DNA
Technologies (Coralville, IA, USA). RNase A from Sigma
Chemical (St. Louis, MO, USA) was used for crystalliza-
tion and structure determination of RNase AÆsulfonamide
complexes. RNase A produced by heterologous expression
[48] was used in assays to determine Ki values. All other
chemicals and biochemicals were of reagent grade or better,
and were used without further puriﬁcation.
Compounds 1–3 [49,50] and 4–7 [51] were synthesized as
described previously, and were generous gifts from T. S.
Fig. 5. Superposition (stereo representation)
of N-acylsulfonamide 6 (gray) and
N-acylsulfonamide 7 (maroon) (this work)
on uridylyl(2¢ﬁ5¢)adenosine (cyan), cytidine
2¢-phosphate (green), 2¢-deoxycytidylyl
(3¢ﬁ5¢)2¢-deoxyadenosine (blue), and
2¢-ﬂuoro-2¢-deoxyuridine 3¢-phosphate (gold)
(PDB codes: 11ba, 1jvu, 1r5c, and 1w4q,
respectively). Sulfur atoms are in yellow;
phosphorus atoms are in forest green.
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Determination of Ki values
Compounds 1–7 were assessed as inhibitors of catalysis of
6-FAM–dArUdAdA–6-TAMRA cleavage by RNase A
[52,53]. Brieﬂy, assays were performed in 2.00 mL of either
0.05 m Bistris⁄HCl buffer at pH 6.0 or 0.05 m Mes⁄NaOH
buffer at pH 6.0, containing NaCl (0.10 m) that also
contained 6-FAM–dArUdAdA–6-TAMRA (0.06 lm) and
RNase A (1–5 pm). Mes was puriﬁed prior to use to remove
inhibitory contaminants, as described previously [54].
Fluorescence (F) was measured with 493 and 515 nm as the
excitation and emission wavelengths, respectively, using a
QuantaMaster 1 Photon Counting Fluorometer equipped
with sample stirring (Photon Technology International,
South Brunswick, NJ, USA). The DF⁄Dt value was measured
for 3 min after the addition of RNase A. An aliquot of the
putative competitive inhibitor (I) dissolved in the assay buffer
was added, and DF⁄Dt was recorded for 3 min. The con-
centration of I was doubled repeatedly at 3-min intervals.
Excess RNase A was then added to the mixture to ensure
that < 10% of the substrate had been cleaved prior to
completion of the inhibition assay. Apparent changes in ribo-
nucleolytic activity caused by dilution were corrected by
comparing values with those from an assay in which aliquots
of buffer were added. Values of Ki for competitive inhibition
were determined by nonlinear least squares regression analy-
sis of data ﬁtted to Eqn (1), where (DF⁄Dt)0 was the activity
prior to the addition of inhibitor.
DF=Dt ¼ð DF=DtÞ0fKi=ðKi þ½ I Þg ð1Þ
X-ray crystallography
Crystals of RNase A were grown by using the hang-
ing drop vapor diffusion method [19]. Crystals of
RNase AÆN-acylsulfonamide complexes were obtained by
soaking crystals in the inhibitor solution containing mother
liquor [0.02 m sodium citrate buffer at pH 5.5, containing
25% (w⁄v) poly(ethylene glycol) 4000]. Diffraction data for
the two complexes were collected at 100 K, with poly(ethyl-
ene glycol) 4000 (30% w⁄v) as a cryoprotectant, on station
PX 9.6 at the Synchrotron Radiation Source (Daresbury,
UK), using a Quantum-4 CCD detector (ADSC Systems,
Poway, CA, USA). Data were processed and scaled in
space group C2 with the hkl2000 software suite [55]. Initial
phases were obtained by molecular replacement, with an
unliganded RNase A structure (PDB code 1afu) as a start-
ing model. Further reﬁnement and model building were car-
ried out with refmac [56] and coot [57], respectively
(Table 2). With each data set, a set of reﬂections (5%) was
kept aside for the calculation of Rfree [58]. The N-acylsulf-
onamide inhibitors were modeled with 2Fo ) FC and
Fo ) FC sigmaa-weighted maps. The ligand dictionary ﬁles
were created with the sketcher tool in the ccp4i inter-
face [59]. All structural diagrams were prepared with
bobscript [60].
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